Drug delivery to the testis: current status and potential pathways for the development of novel therapeutics

Drug Delivery and Translational Research
Devon C Snow-LisyEdmund S Sabanegh

Abstract

Nanotechnology has been increasingly utilized for the targeting and delivery of novel therapeutic agents to different tissues and cell types. The current therapeutic options for testicular disorders fall short in many instances due to difficulty traversing the blood-testis barrier, systemic toxicities, and complicated dosing regiments. For testicular tissue, potential targeting can be obtained either via anatomic methods or specific ligands such as luteinizing hormone or follicle-stimulating hormone analogs. Potential novel therapeutic agents include DNA, RNA, cytokines, peptide receptor antagonists, peptide receptor agonists, hormones, and enzymes. Nanotherapeutic treatment of testicular cancer, infertility, testicular torsion, orchalgia, hypogonadism, testicular infections, and cryptorchidism within the framework of potential target cells are an emerging area of research. While there are many potential applications of nanotechnology in drug delivery to the testis, this remains a relatively unexplored field. This review highlights the current status as well as potential future of nanotechnology in the development of novel therapeutics for testicular disorders.

References

Apr 1, 1992·Baillière's Clinical Endocrinology and Metabolism·J B Kerr
Oct 1, 1988·The British Journal of Surgery·J B Anderson, R C Williamson
Feb 1, 1986·Clinics in Endocrinology and Metabolism·R M Sharpe
Feb 1, 1986·Clinics in Endocrinology and Metabolism
Mar 18, 1994·Science·R GrefR Langer
Mar 1, 1996·Archives of Histology and Cytology·M MaekawaT Nagano
Jan 4, 1998·Biology of Reproduction·T T TurnerL W Wilson
Jul 27, 1999·World Journal of Urology·E W Rugendorff
Feb 7, 2001·The Journal of Clinical Endocrinology and Metabolism·S M HarmanUNKNOWN Baltimore Longitudinal Study of Aging
Jun 11, 2003·The Journal of Urology·Eric HuyghePatrick Thonneau
Jul 31, 2003·BJU International·A J Visser, C F Heyns
Aug 9, 2003·Molecular Endocrinology·Hanumanthappa KrishnamurthyMario Ascoli
Dec 18, 2003·Drug Discovery Today·Sanjeeb K Sahoo, Vinod Labhasetwar
Mar 26, 2004·European Urology·P Granitsiotis, D Kirk
Aug 10, 2004·The Journal of Experimental Biology·David S WarnerInes Batinić-Haberle
Mar 12, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Thomas M Ulbright
Jul 21, 2005·International Journal of Cancer. Journal International Du Cancer·Meaghan L DouglasDavid L Nicol
Aug 8, 2007·International Journal of Pharmaceutics·Avinash BudhianKaren I Winey
Feb 5, 2008·Animal Reproduction Science·Larry JohnsonDickson D Varner
Feb 19, 2008·Human Reproduction Update·Kelton Tremellen
Jan 1, 1996·Infectious Diseases in Obstetrics and Gynecology·S S WitkinM G Munoz
May 17, 2008·Pharmacological Reviews·Dolores D MrukC Yan Cheng
Jun 24, 2008·Journal of Andrology·Terry T Turner, Jeffrey J Lysiak
Apr 25, 2009·Advanced Drug Delivery Reviews·Veronica I ShubayevSungho Jin
Oct 22, 2009·Small·Ayush Verma, Francesco Stellacci
Feb 4, 2010·Cell Biology and Toxicology·Stephen L Hart
Mar 5, 2010·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Dominique SegretainGeorges Pointis
May 22, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Laura K Braydich-StolleMarie-Claude Hofmann
Oct 22, 2010·The New England Journal of Medicine·Aurelian RaduNicolae Ghinea
Dec 2, 2010·Human Fertility : Journal of the British Fertility Society·A C Povey, S J Stocks
Jan 18, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Baris E PolatDaniel Blankschtein
Feb 22, 2011·Nursing for Women's Health·Karen C Lee
Mar 16, 2011·Nature Reviews. Urology·Katrine BayNiels E Skakkebæk
Mar 23, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Carola HeneweerJason S Lewis
Jul 27, 2011·Therapeutic Advances in Urology·Michael R Pinsky, Wayne J G Hellstrom

❮ Previous
Next ❯

Citations

Mar 23, 2015·The Journal of Urology·Devon C Snow-LisyVinod Labhasetwar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu
Nancy Q Zhong, Molly J Wang
Journal of the National Cancer Institute
R H DepueB E Henderson
The Journal of Urology
P J Van CanghP Malvaux
Current Pharmaceutical Biotechnology
Xiaoyan Zhang, Congjian Xu
© 2021 Meta ULC. All rights reserved